tiprankstipranks
Cyclo Therapeutics (CYTH)
NASDAQ:CYTH
US Market

Cyclo Therapeutics (CYTH) Financial Statements

189 Followers

Cyclo Therapeutics Financial Overview

Cyclo Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.003; its P/E ratio is -1.21; Cyclo Therapeutics is scheduled to report earnings on August 13, 2024, and the estimated EPS forecast is $-0.15. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 311.40K$ 495.50K$ 117.12K$ 152.41K$ 186.80K
Gross Profit$ 295.90K$ 536.39K$ 144.49K$ -12.27K$ -17.85K
EBIT$ -5.64M$ -4.77M$ -4.64M$ -5.01M$ -4.98M
EBITDA$ -5.64M$ -4.77M-$ -5.01M$ -5.10M
Net Income Common Stockholders$ -5.64M$ -4.77M$ -4.64M$ 5.22M$ -4.82M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 9.25M$ 1.80M$ 841.53K$ 915.18K$ 1.54M
Total Assets$ 13.25M$ 5.60M$ 4.64M$ 4.10M$ 4.22M
Total Debt$ 1.03M$ 45.23K$ 49.41K$ 53.50K$ 0.00
Net Debt$ -8.21M$ -1.76M$ -792.13K$ -861.68K$ -1.54M
Total Liabilities$ 8.49M$ 6.65M$ 6.13M$ 4.54M$ 3.48M
Stockholders Equity$ 4.76M$ -1.05M$ -1.48M$ -438.88K$ 734.54K
Cash Flow-
Free Cash Flow$ -4.30M$ -4.04M-$ -4.37M$ -2.75M
Operating Cash Flow$ -4.30M$ -4.04M-$ -4.37M$ -2.75M
Investing Cash Flow$ -2.42K----
Financing Cash Flow$ 11.74M$ 5.00M-$ 3.74M-
Currency in USD

Cyclo Therapeutics Earnings and Revenue History

Cyclo Therapeutics Debt to Assets

Cyclo Therapeutics Cash Flow

Cyclo Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis